Search results for "Hepatic Artery"

showing 10 items of 26 documents

Enhancement pattern of hepatocellular adenoma (HCA) on MR imaging performed with Gd-EOB-DTPA versus other Gd-based contrast agents (GBCAs): An intrai…

2019

Purpose: To conduct an intraindividual comparison of the enhancement pattern of hepatocellular adenoma (HCA) on dynamic MRI study obtained following the injection of Gadoxetic acid (Gd-EOB-DTPA) and other gadolinium-based contrast agents (GBCAs).Method: This is a retrospective, Institutional Review Board-approved study conducted in a single institution. A search of medical records between 2008 and 2017 revealed 17 patients (all females) with at least one pathologically-proven HCA who underwent liver MRI with Gd-EOB-DTPA and another GBCA within 1 year. Enhancement of each lesion on hepatic arterial (HAP), portal venous (PVP), 2 min and 4-5 minutes phases was subjectively evaluated by two abd…

AdultGadolinium DTPAMaleGadoxetic acidGadoliniumPopulationchemistry.chemical_elementContrast Media030218 nuclear medicine & medical imagingAdenoma Liver CellLesion03 medical and health sciences0302 clinical medicineMcNemar's testHepatic ArterymedicineHumansRadiology Nuclear Medicine and imagingeducationAgedRetrospective Studieseducation.field_of_studymedicine.diagnostic_testbusiness.industryPortal VeinLiver NeoplasmsMagnetic resonance imagingGeneral MedicineHepatocellular adenomaMiddle Agedmedicine.diseaseMagnetic Resonance Imagingchemistry030220 oncology & carcinogenesisDynamic contrast-enhanced MRIFemalemedicine.symptomLiver Contrast media Hepatocellular adenoma Magnetic resonance imagingbusinessNuclear medicineSettore MED/36 - Diagnostica Per Immagini E Radioterapiamedicine.drug
researchProduct

Congenital hepatic fibrosis: CT findings in 18 adults.

2004

To evaluate the computed tomographic (CT) findings in adult patients with pathologically proved congenital hepatic fibrosis.This was a retrospective review of congenital hepatic fibrosis cases identified at two institutions over the course of 8 years. Eight men and 10 women with an age range of 22-72 years (mean age, 39 years) were included. Contrast material-enhanced and unenhanced CT scans were obtained through the liver in all patients. Two radiologists evaluated size of and morphologic findings (atrophy or hypertrophy localized according to hepatic segments) in the liver; increased diameter or number of hepatic arteries at the hilum; presence of hepatic nodules, varices, spontaneous spl…

AdultLiver CirrhosisMalemedicine.medical_specialtyCommon Bile Duct Diseasesmedicine.medical_treatmentSplenectomyHilum (biology)Hepatic VeinsKidneyGastroenterologyHepatic ArteryAtrophyFibrosisInternal medicineHypertension PortalHumansMedicineRadiology Nuclear Medicine and imagingAgedRetrospective StudiesPortal Veinbusiness.industryHypertrophyMiddle Agedmedicine.diseaseDuctal Plate MalformationLiverPortal hypertensionCongenital hepatic fibrosisFemaleRadiologyTomography X-Ray ComputedbusinessVaricesDilatation PathologicFollow-Up Studies
researchProduct

Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.

2012

Abstract Aims The aim of this study is to evaluate factors associated with the outcome after surgical resection and to compare the efficacy of surgery to transarterial chemoembolisation (TACE) in patients with advanced intrahepatic cholangiocarcinoma (IHC). Materials and methods 273 patients with IHC treated in our department between 1997 and 2012 were included in our study. Patients were divided according to therapy into surgical ( n  = 130), TACE ( n  = 32), and systemic chemotherapy/best supportive care ( n  = 111) groups. Clinicopathological characteristics and survival were reviewed retrospectively. Results The 1-, 3-, and 5-year survival rates in patients after surgical resection were…

AdultLiver CirrhosisMalemedicine.medical_specialtyKaplan-Meier EstimateSingle CenterCholangiocarcinomaHepatic ArteryAntineoplastic Combined Chemotherapy ProtocolsBiomarkers TumorMedicineHumansChemoembolization TherapeuticLymph nodeIntrahepatic CholangiocarcinomaAgedRetrospective StudiesAged 80 and overUnivariate analysisAnalysis of Variancebusiness.industryBile ductLiver NeoplasmsRetrospective cohort studyGeneral MedicineMiddle AgedSurgerymedicine.anatomical_structureBile Ducts IntrahepaticTreatment OutcomeOncologyBile Duct NeoplasmsChemotherapy AdjuvantResection marginSurgeryFemalePositive Surgical MarginbusinessEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
researchProduct

Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II …

2019

Abstract Background Hepatic arterial embolisation therapy (HAET) is a treatment of liver metastases of gastrointestinal neuroendocrine tumours (GI-NETs). HAET increases circulating vascular endothelial growth factor levels. Everolimus is a treatment in NETs that may have antiangiogenic activity. Methods This phase II study was conducted in patients with predominant and progressive liver metastases from GI-NETs. Everolimus was initiated 7–30 days after HAET. The hypothesis was that everolimus after HAET would increase hepatic progression-free survival (hPFS) rate at 24 months from 35% to 50%. Results Among the 74 patients included, 88% had small-bowel primary tumour, 43% had grade I and 57% …

AdultMale0301 basic medicineCancer Researchmedicine.medical_specialtyLung NeoplasmsPhases of clinical researchAntineoplastic AgentsBone NeoplasmsGastroenterologyStreptozocin03 medical and health scienceschemistry.chemical_compoundHepatic Artery0302 clinical medicineInternal medicineMucositisHumansMedicineIn patientEverolimusChemoembolization TherapeuticTrial registrationPeritoneal NeoplasmsAgedGastrointestinal NeoplasmsAged 80 and overGastrointestinal tractAntibiotics AntineoplasticEverolimusbusiness.industryLiver NeoplasmsMiddle Agedmedicine.diseaseEmbolization TherapeuticProgression-Free SurvivalConfidence intervalVascular endothelial growth factorNeuroendocrine Tumors030104 developmental biologyOncologychemistryDoxorubicin030220 oncology & carcinogenesisFemaleLymph Nodesbusinessmedicine.drugEuropean Journal of Cancer
researchProduct

Incidence of liver retransplantation and its effect on patient survival.

2008

Purpose. The purpose of this study was to review our institutional experience with re-liver transplantation (OLT) after split and full-size OLT. Patients and methods. We evaluated data corresponding to retransplanted patients over an 8-year period who underwent deceased donor OLT at our institution. Variables analyzed included indications for primary OLT, and re-OLT, the type of graft used during the initial versus re-OLT, the time from initial to re-OLT, and patient survival after re-OLT. Results. Sixty-four of 697 first OLT (9.2%) required re-OLT. Forty-nine cases were among 637 (7.6%) full-size OLT, while 15 were among 60 (25%) split OLT (P <.001). Median time to re-OLT was 8 days (range…

AdultMaleReoperationmedicine.medical_specialtyAdolescentYoung AdultOverall survivalMedicineHumansSurvivorsAgedRetrospective StudiesTransplantationDeceased donorbusiness.industryIncidence (epidemiology)Patient SelectionPatient survivalHepatitis CMiddle Agedmedicine.diseaseSurgeryLiver TransplantationTransplantationSurvival RateHepatic artery thrombosissurgical procedures operativeMedian timeSurgeryFemalebusinessTransplantation proceedings
researchProduct

Arterially enhancing liver lesions: significance of sustained enhancement on hepatic venous and delayed phase with magnetic resonance imaging.

2007

Benign hepatic vascular neoplasms and vascular pseudolesions are commonly encountered in magnetic resonance (MR) imaging. Most of these benign lesions demonstrate not only arterial-phase hyperintensity, but also persistent enhancement on venous and delayed imaging, unlike most malignant hepatic masses. These features, along with other MR findings and morphological characteristics, may allow for more confident diagnosis and distinction from hepatic malignancy. The objective of our study was to illustrate the MR imaging findings of hepatic lesions that demonstrate both early arterial and sustained enhancement on hepatic venous and delayed phase.

AdultMalemedicine.medical_specialtyHepatic VeinsHepatic ArteryVascular NeoplasmmedicineDelayed imagingHumansRadiology Nuclear Medicine and imagingmedicine.diagnostic_testbusiness.industryLiver DiseasesLiver NeoplasmsMagnetic resonance imagingDelayed phaseMiddle AgedMr imagingMagnetic Resonance ImagingHepatic malignancyHyperintensityRadiographic Image EnhancementRadiographic Image EnhancementFemaleRadiologyNuclear medicinebusinessJournal of computer assisted tomography
researchProduct

Heterogeneous delayed enhancement of hepatic parenchyma after intravenous infusion of sonographic contrast agent: a new hypothesis

2007

Purpose. The aim of this paper was to report a heterogeneous latephase hepatic enhancement pattern observed after administration of a sonographic contrast agent and to present an aetiological hypothesis for the phenomenon. Materials and methods. A total of 1,729 (1,012 women and 717 men; age range 28–82; mean age 51) patients underwent contrastenhanced sonography of the liver. The examination was performed with a low mechanical index (MI <0.09) after injection of sulphur-hexafluoride-filled microbubbles, using different fonographic equipment and different contrast-specific algorithms. Results. Heterogeneous delayed liver enhancement was observed in six patients in the late phase (180 s), wi…

AdultMalemedicine.medical_specialtyPathologyTime FactorsSulfur HexafluorideContrast MediaHepatic ArteryMesenteric VeinsmedicineHumansRadiology Nuclear Medicine and imagingSuperior mesenteric veinInfusions IntravenousUltrasound Microbubbles LiverPhospholipidsAgedUltrasonographyNeuroradiologyAged 80 and overMicrobubblesmedicine.diagnostic_testPortal Veinbusiness.industryUltrasoundEchogenicityInterventional radiologyGeneral MedicineMiddle AgedImage EnhancementPeripheralLiverMicrobubblesFemaleRadiologySettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessMechanical indexLiver CirculationLa radiologia medica
researchProduct

Centrifugal (inside-out) enhancement of liver hemangiomas: a possible atypical appearance on contrast-enhanced US.

2007

Abstract Objective To report the prevalence and to describe the atypical centrifugal (inside-out) appearance of contrast-enhancement of liver hemangiomas on contrast-enhanced sonography. Materials and methods Baseline and SonoVue ® -enhanced ultrasonography of 92 patients with 158 liver hemangiomas – considered atypical at grey-scale examination and confirmed by computed tomography, magnetic resonance imaging and ultrasound follow-up – were reviewed in consensus by two experienced radiologists, who evaluated baseline echogenicity and the dynamic enhancement pattern of each lesion looking for the presence of central enhancing foci in the arterial phase followed by a centrifugal (inside-out) …

AdultMalemedicine.medical_specialtyTime FactorsSecond-harmonic imaging microscopySulfur HexafluorideContrast MediaAngiomaHepatic ArterymedicineImage Processing Computer-AssistedHumansRadiology Nuclear Medicine and imagingUltrasonography Doppler ColorPhospholipidsAgedMicrobubblesmedicine.diagnostic_testbusiness.industryVascular diseasePortal VeinUltrasoundLiver NeoplasmsEchogenicityMagnetic resonance imagingUltrasonography DopplerGeneral MedicineMiddle Agedmedicine.diseaseImage EnhancementMagnetic Resonance ImagingUltrasonography Doppler PulsedLiver HemangiomaFemaleRadiologyTomographybusinessHemangiomaTomography X-Ray ComputedFollow-Up StudiesEuropean journal of radiology
researchProduct

Hepatic Hilar and Sectorial Vascular and Biliary Anatomy in Right Graft Adult Live Liver Donor Transplantation

2008

Abstract Introduction The aim of this study was to analyze vascular and biliary variants at the hilar and sectorial level in right graft adult living donor liver transplantation. Methods From January 2003 to June 2007, 139 consecutive live liver donors underwent three-dimensional computed tomography (3-D CT) reconstructions and virtual 3-D liver partitioning. We evaluated the portal (PV), arterial (HA), and biliary (BD) anatomy. Results The hilar and sectorial biliary/vascular anatomy was predominantly normal (70%–85% and 67%–78%, respectively). BD and HA showed an equal incidence (30%) of hilar anomalies. BD and PV had a nearly identical incidence of sectorial abnormalities (64.7% and 66.2…

Adultmedicine.medical_specialtyCholecystographymedicine.medical_treatmentHilum (biology)Hepatic VeinsLiver transplantationliverHepatic ArteryImage Processing Computer-AssistedLiving DonorsmedicineHumansPorta hepatisTransplantationmedicine.diagnostic_testbusiness.industryGallbladderCholecystographyLiver TransplantationSurgeryTransplantationmedicine.anatomical_structureBiliary tractCirculatory systemSurgeryHepatectomyTomography X-Ray ComputedNuclear medicinebusinessTransplantation Proceedings
researchProduct

Destruction of Kupffer’s cells increases total liver blood flow and decreases ischemia reperfusion injury in pigs

2000

Cellular immunityPathologymedicine.medical_specialtyAdenosineCell SurvivalKupffer CellsSwineAllopurinolmedicine.medical_treatmentOrgan Preservation SolutionsIschemiaHemodynamicsGadoliniumVena Cava InferiorHepatic ArteryRaffinoseAnimalsInsulinMedicineTransplantationChemotherapyPortal Veinbusiness.industryAnastomosis SurgicalKupffer cellOrgan PreservationBlood flowmedicine.diseaseGlutathioneLiver TransplantationTransplantationmedicine.anatomical_structureLiverRegional Blood FlowReperfusion InjuryImmunologySurgerybusinessReperfusion injuryLiver CirculationTransplantation Proceedings
researchProduct